Literature DB >> 36160069

Fluoxetine Related Urinary Retention in a 15-Year-Old Girl: a Case Report.

Ömer Faruk Bulut1, Ali Karayağmurlu1, İlyas Kaya1.   

Abstract

Fluoxetine is an effective and safe agent frequently used in the treatment of childhood depression and obsessive-compulsive disorder. Urinary retention is defined as the inability to empty the bladder completely. Drug use is one of the most important factors in the etiology of urinary retention. Urinary retention is an uncommon side-effect of fluoxetine use. We report a case of chronic urinary retention during fluoxetine monotherapy in a 15-year-old girl, resolving following the discontinuation of treatment. Copyright:
© 2022 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Fluoxetine; SSRI; adolescent; adverse effect; urinary retention

Year:  2022        PMID： 36160069      PMCID： PMC9466638          DOI： 10.29399/npa.27938

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN： 1300-0667            Impact factor:   1.066


  12 in total

1.  Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine.

Authors:  E Le Poul; C Boni; N Hanoun; A M Laporte; N Laaris; J Chauveau; M Hamon; L Lanfumey
Journal:  Neuropharmacology       Date:  2000       Impact factor: 5.250

2.  Urinary Retention in an Adolescent Patient Caused by Fluoxetine Alone.

Authors:  Mehmet Karadag; Cem Gokcen; Hasan Bayar; Ihsan Aksoy
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-10       Impact factor: 2.576

Review 3.  Drug-induced urinary retention: incidence, management and prevention.

Authors:  Katia M C Verhamme; Miriam C J M Sturkenboom; Bruno H Ch Stricker; Ruud Bosch
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Urinary retention with fluoxetine-haloperidol combination in a young patient.

Authors:  F Benazzi
Journal:  Can J Psychiatry       Date:  1996-11       Impact factor: 4.356

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 6.  Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance.

Authors:  Elliott Richelson
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

Review 7.  Urinary retention in adults: diagnosis and initial management.

Authors:  Brian A Selius; Rajesh Subedi
Journal:  Am Fam Physician       Date:  2008-03-01       Impact factor: 3.292

8.  Dimensional assessment of posttraumatic stress disorder in DSM-5.

Authors:  Richard LeBeau; Emily Mischel; Heidi Resnick; Dean Kilpatrick; Matthew Friedman; Michelle Craske
Journal:  Psychiatry Res       Date:  2014-04-05       Impact factor: 3.222

9.  Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects.

Authors:  U Jain; B Birmaher; M Garcia; M Al-Shabbout; N Ryan
Journal:  J Child Adolesc Psychopharmacol       Date:  1992       Impact factor: 2.576

10.  Investigation of the role of 5-HT2 receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat.

Authors:  Y Mbaki; A G Ramage
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.